CPLD 2006 FFHMFAC vs Respondent M05

Facts
The French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding (Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme, FFHMFAC) charges respondent M05 for a violation of the Anti-Doping Rules. During a contest on January 16, 2005, a sample was taken for doping test purposes. Analysis of the sample showed the presence of 19-norandrosterone, epimethendiol (17α-methyl-5β-androstane-3α,17β-diol), two metabolites of metandienone (6β-hydroxymethandienone, 17-epimethandienone) and testosterone or its precursors which are prohibited substances according the World Anti-Doping Agency (WADA) prohibited list.

History
The respondent admits the use of the steroids to enhance his sport performances, but appealed against the decision of the disciplinary committee for a reduction of the sanction because it was his first violation.

Decision
1. The sanction is a period of ineligibility of three years in which respondent can't take part in competition or manifestations organized or authorized by the FFHMFAC.
2. The decision start on the date of notification.
3. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
5 January 2006
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Admission
Aggravating circumstances
Period of ineligibility
Sport/IFs
Weightlifting (IWF) - International Weightlifting Federation
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Conseil de Prévention et de Lutte contre le Dopage (CPLD) - Council to Prevent and Counteract Doping
Fédération Française d'Halterophilie, Musculation, Force Athlétique et Culturisme (FFHMFAC) - French Federation of Weightlifting, Fitness, Powerlifting and Bodybuilding
Fédération française d'haltérophilie-musculation (FFHM) - French Weightlifting-Bodybuilding Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S1. Anabolic Agents
Substances
17α-methyl-5β-androstane-3α,17β-diol
19-norandrosterone
Metandienone (17β-hydroxy-17α-methylandrosta-1,4-dien-3-one)
Testosterone
Document type
Pdf file
Date generated
22 September 2014
Date of last modification
13 February 2024
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin